Harry Burn Sound Shore Management
Harry Burn is a co-founder of Sound Shore Management, a firm focused on large-cap value equities selected through fundamental research. Sound Shore is known for a disciplined valuation process and a relatively compact list of portfolio holdings. The firm is often cited among long-standing institutional value managers with a public-markets track record.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$73.8M |
| 2 |
Acuity Brands
AYI
|
+$58.5M |
| 3 |
TotalEnergies
TTE
|
+$22.3M |
| 4 |
HOLX
Hologic
HOLX
|
+$21.2M |
| 5 |
Micron Technology
MU
|
+$20M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robert Half
RHI
|
+$53.8M |
| 2 |
Vistra
VST
|
+$45.9M |
| 3 |
Constellation Energy
CEG
|
+$39.2M |
| 4 |
NXP Semiconductors
NXPI
|
+$35.6M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$24.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.85% |
| 2 | Technology | 20.78% |
| 3 | Industrials | 12.88% |
| 4 | Financials | 9.55% |
| 5 | Energy | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Organon & Co
OGN
$3.61B
| $60M | 2.3% |
3,458,615
-320,640
| -8% | -$6.69M |
|
27
Oracle
ORCL
$422B
| $59.8M | 2.29% |
564,515
-2,709
| -0.5% | -$314K |
|
28
Analog Devices
ADI
$182B
| $59.7M | 2.28% |
340,732
-1,477
| -0.4% | -$272K |
|
|
29
Constellation Energy
CEG
$96.7B
| $57.9M | 2.22% |
530,594
-379,984
| -42% | -$39.2M |
|
30
Cleveland-Cliffs
CLF
$6.43B
| $57.9M | 2.22% |
3,702,768
-491,796
| -12% | -$7.68M |
|
31
PACCAR
PCAR
$69B
| $56.3M | 2.16% |
662,121
-81,863
| -11% | -$6.96M |
|
32
Baker Hughes
BKR
$61.9B
| $56.1M | 2.15% |
1,588,700
-526,483
| -25% | -$18.6M |
|
33
Pfizer
PFE
$160B
| $55.2M | 2.12% |
1,665,647
-126,900
| -7% | -$4.49M |
|
34
Lennar Class A
LEN
$21B
| $55.2M | 2.11% |
508,015
+45,968
| +10% | +$5.39M |
|
35
Cisco
CSCO
$438B
| $54.8M | 2.1% |
1,018,729
-303,972
| -23% | -$16.4M |
|
36
Applied Materials
AMAT
$391B
| $54M | 2.07% |
390,197
-1,804
| -0.5% | -$259K |
|
37
Conagra Brands
CAG
$7.89B
| $41.7M | 1.6% |
1,522,008
-92,833
| -6% | -$2.86M |
|
38
Bath & Body Works
BBWI
$3.92B
| $13.4M | 0.51% |
+397,148
| New | +$14.4M |
|
|
39
Robert Half
RHI
$4.58B
| – | – |
-715,537
| Closed | -$53.8M |
|
Similar funds
Harry Burn's Q3 2023 Portfolio in Review
As of Q3 2023, Harry Burn held 40 positions worth $2.61B, down 3.7% from $2.71B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Harry Burn's Q3 2023 filing shows 3 new, 13 increased, 22 reduced and 2 closed positions. Its largest new stake was Teva Pharmaceuticals: 7,920,712 shares worth $80.8M. The largest sale was Robert Half, an estimated $53.8M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.
- Harry Burn's largest Q3 2023 buy was Teva Pharmaceuticals: 7,920,712 shares worth $80.8M.
- Harry Burn added most to TotalEnergies in Q3 2023, an estimated $22.3M increase.
- Harry Burn's biggest Q3 2023 reduction was Vistra, cutting an estimated $45.9M.
- Harry Burn fully exited Robert Half in Q3 2023, selling an estimated $53.8M.
- Harry Burn's ten largest holdings make up 34% of its $2.61B portfolio in Q3 2023.
- Harry Burn opened 3 new positions and closed 2 in Q3 2023.
- Harry Burn's portfolio value fell 3.7% quarter-over-quarter to $2.61B.
Based on Sound Shore Management's 13F filing for Q3 2023, filed 6 Nov 2023.